AI drug discovery brings $2B+ Sanofi deal to 1-year-old Earendil

FierceBiotechFrom executive assistant to chief executive: Charles River CEO Birgit Girshick on ‘the next big transition’ in the CRO industry

Endpoints NewsParabilis CEO Mathai Mammen on biotech's record IPO

AgilentAgilent Partners with OpenAI and BCG to Advance Artificial Intelligence in Lab Workflows - Clinical Lab Products

Promega BlogPromega Builds Opportunity to Appreciate Hidden Wetland

FierceBiotechADA: Novo’s Lange says ‘jury still out’ on CagriSema amid tough retatrutide comparisons

BioPharma DiveEthyreal starts up with $101M and takes aim at a pair of immune diseases

Clinical OMICsEngineered Salmonella Delivers Cancer-Killing Virus to Tumors

Endpoints NewsNovartis and Orionis strike second molecular glue deal for $40M upfront

FierceBiotechGLP-1s may combat depression by multiplying a mood-boosting gut microbe

BioPharma DiveSanofi stops immune drug trial in latest research setback

Endpoints NewsSonoThera raises $125M for non-viral gene therapy approach

BioPharma DiveParabilis sets a record with a $670M biotech IPO